We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-2.16%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$410M
AUM Growth
+$95.1M
Cap. Flow
+$111M
Cap. Flow %
27.15%
Top 10 Hldgs %
61.88%
Holding
29
New
2
Increased
18
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$13.5M
2
CANO
Cano Health, Inc.
CANO
+$13.4M
3
UTHR icon
United Therapeutics
UTHR
+$10.9M
4
AMWL icon
American Well
AMWL
+$10.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$10.2M

Top Sells

Rank Stock Value
1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$8.2M
2
DXCM icon
DexCom
DXCM
+$1.61M
3
OM icon
Outset Medical
OM
+$188K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUM icon
1
Humana
HUM
$46.3B
$36.5M 8.89%
78,621
+10,100
+15% +$4.47M
AZN icon
2
AstraZeneca
AZN
$251B
$35.6M 8.68%
305,833
+81,050
+36% +$9.54M
UTHR icon
3
United Therapeutics
UTHR
$22.7B
$33.2M 8.08%
153,438
+55,400
+57% +$10.9M
IQV icon
4
IQVIA
IQV
$39.8B
$28.1M 6.85%
99,577
+18,400
+23% +$4.77M
ARGX icon
5
argenx
ARGX
$54.2B
$21.8M 5.32%
62,332
+8,700
+16% +$2.65M
ADPT icon
6
Adaptive Biotechnologies
ADPT
$4.05B
$21.1M 5.13%
750,760
+309,294
+70% +$9.48M
BPMC
7
DELISTED
Blueprint Medicines
BPMC
$20.6M 5.03%
192,639
+16,464
+9% +$1.72M
NTRA icon
8
Natera
NTRA
$45.9B
$19.8M 4.82%
211,694
+47,200
+29% +$4.9M
ALNY icon
9
Alnylam Pharmaceuticals
ALNY
$29B
$19.3M 4.7%
113,702
+23,600
+26% +$4.39M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$133B
$18M 4.4%
82,144
+52,600
+178% +$10.2M
INSP icon
11
Inspire Medical Systems
INSP
$1.73B
$17.5M 4.27%
76,253
+7,600
+11% +$1.86M
CANO
12
DELISTED
Cano Health, Inc.
CANO
$17.4M 4.23%
19,478
+12,714
+188% +$13.4M
OM icon
13
Outset Medical
OM
$91.4M
$15.2M 3.69%
21,933
-254
-1% -$188K
AXNX
14
DELISTED
Axonics, Inc. Common Stock
AXNX
$14.4M 3.5%
256,465
+66,100
+35% +$4.04M
DXCM icon
15
DexCom
DXCM
$33.1B
$14.3M 3.49%
106,800
-11,200
-9% -$1.61M
AGIO icon
16
Agios Pharmaceuticals
AGIO
$1.95B
$14.2M 3.46%
431,413
+195,900
+83% +$7.89M
AMWL icon
17
American Well
AMWL
$231M
$13.6M 3.31%
112,395
+67,330
+149% +$10.3M
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
$12.4M 3.03%
+80,500
New +$13.5M
GH icon
19
Guardant Health
GH
$22.4B
$11.9M 2.91%
119,360
+23,700
+25% +$2.45M
MRTX
20
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$7.63M 1.86%
52,000
– –
CMAX
21
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$5.49M 1.34%
23,825
+3,266
+16% +$777K
FDMT icon
22
4D Molecular Therapeutics
FDMT
$582M
$2.9M 0.71%
132,090
+75,000
+131% +$1.84M
KYMR icon
23
Kymera Therapeutics
KYMR
$9.03B
$2.35M 0.57%
37,000
– –
BEAM icon
24
Beam Therapeutics
BEAM
$2.82B
$2.3M 0.56%
+28,900
New +$2.47M
ARVN icon
25
Arvinas
ARVN
$588M
$1.89M 0.46%
23,000
– –
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Eagle Health Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Eagle Health Investments held 29 positions worth $410M, up 30% from $315M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eagle Health Investments deployed $111M of net new capital in Q4 2021, opening 2 new positions and adding to 18 existing holdings. Its largest new stake was Seagen Inc. Common Stock: 80,500 shares worth $12.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 97% a quarter earlier.

On the sell side, the largest reduction was DexCom, an estimated $1.61M trimmed.

  • Eagle Health Investments's largest Q4 2021 buy was Seagen Inc. Common Stock: 80,500 shares worth $12.4M.
  • Eagle Health Investments added most to Cano Health, Inc. in Q4 2021, an estimated $13.4M increase.
  • Eagle Health Investments's biggest Q4 2021 reduction was DexCom, cutting an estimated $1.61M.
  • Eagle Health Investments fully exited Dicerna Pharmaceuticals, Inc. in Q4 2021, selling an estimated $8.2M.
  • Eagle Health Investments's ten largest holdings make up 62% of its $410M portfolio in Q4 2021.
  • Eagle Health Investments opened 2 new positions and closed 1 in Q4 2021.
  • Eagle Health Investments's portfolio value rose 30% quarter-over-quarter to $410M.

Based on Eagle Health Investments's 13F filing for Q4 2021, filed 10 Feb 2022.